欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3260/002
药品名称Amoxicillin/Clavulanic acid Centrient 875 mg/125 mg powder for oral suspension in sachet
活性成分
    • amoxicillin trihydrate 574.0 mg
    • clavulanic acid potassium salt 125.0 mg
剂型Powder for oral suspension
上市许可持有人Centrient Pharmaceuticals Netherlands B.V. Alexander Fleminglaan 1 2613 AX Delft The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Amoxicilline/Clavulaanzuur Centrient 875 mg/125 mg poeder voor orale suspensie in sachet
互认成员国 - 产品名称
    许可日期2015/10/07
    最近更新日期2023/04/06
    药物ATC编码
      • J01CR02 amoxicillin and beta-lactamase inhibitor
    申请类型
    • TypeLevel1：Known Active Substance
    • TypeLevel2：Initial Application
    • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
    • TypeLevel4：Chemical Substance
    • TypeLevel5：Prescription Only
    附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase